Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gurell

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Anticancer Research|December 27, 2017
Bevacizumab Added to Moderate-dose Chemotherapy for Refractory Uterine CancerHoward W Bruckner, Daniel Gurell, Azriel Hirschfeld
The American Journal of Medicine|September 27, 2006
COPD?Meir H Scheinfeld, Theodore Maniatis, Daniel Gurell
Plos One|November 2, 2022
Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival timesHoward W Bruckner, Fred Bassali, Elisheva Dusowitz, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 8, 2006
Superficial femoral artery occlusive disease severity correlates with MR cine phase-contrast flow measurementsKiyarash Mohajer, Honglei Zhang, Daniel Gurell, et al.
Frontiers in Oncology|July 9, 2024
Cholangiocarcinoma, sequential chemotherapy, and prognostic testsHoward W Bruckner, Robert De Jager, Elisheva Knopf, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Anticancer Research|December 27, 2017
Bevacizumab Added to Moderate-dose Chemotherapy for Refractory Uterine CancerHoward W Bruckner, Daniel Gurell, Azriel Hirschfeld
The American Journal of Medicine|September 27, 2006
COPD?Meir H Scheinfeld, Theodore Maniatis, Daniel Gurell
Plos One|November 2, 2022
Actionable tests and treatments for patients with gastrointestinal cancers and historically short median survival timesHoward W Bruckner, Fred Bassali, Elisheva Dusowitz, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 8, 2006
Superficial femoral artery occlusive disease severity correlates with MR cine phase-contrast flow measurementsKiyarash Mohajer, Honglei Zhang, Daniel Gurell, et al.
Frontiers in Oncology|July 9, 2024
Cholangiocarcinoma, sequential chemotherapy, and prognostic testsHoward W Bruckner, Robert De Jager, Elisheva Knopf, et al.
Pageof 1